Price Alert

Lithia Motors Inc. (LAD)

NYSE: LAD · Real-Time Price · USD

307.26

-4.41 (-1.41%)

At close: Oct 15, 2025, 3:59 PM

307.17

-0.03%

After-hours: Oct 15, 2025, 06:22 PM EDT

-1.41% (1D)

Bid	307.17
Market Cap	7.88B
Revenue (ttm)	37.16B
Net Income (ttm)	890.9M
EPS (ttm)	34.72
PE Ratio (ttm)	8.85
Forward PE	8.01
Analyst	Buy
Dividends	$2.69

Ask	316.12
Volume	175,239
Avg. Volume (20D)	320,396
Open	308.24
Previous Close	311.67
Day's Range	306.50 - 316.83
52-Week Range	262.10 - 405.68
Beta	1.27
Ex-Dividend Date	Aug 8, 2025

About LAD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LAD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LAD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Lithia Motors Inc. is scheduled to release its earnings on Oct 22, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 days ago

-2.03%

Shares of auto and auto-related companies are trad... Unlock content with Pro Subscription

2 months ago

-5.63%

Lithia Motors shares are trading lower after the company reported worse-than-expected Q2 sales results.

News

14 hours ago · zacks.com

Lithia Motors (LAD) Reports Next Week: Wall Street Expects Earnings Growth

Lithia Motors (LAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 day ago · businesswire.com

The Presidio Group Exclusively Advised Stivers Family in Sale of Stivers Subaru in Decatur, Ga., to Lithia & Driveway

DECATUR, Ga.--(BUSINESS WIRE)--The Presidio Group LLC (“Presidio”), an independent merchant banking firm focused on mergers and acquisitions, capital raising and investments in the automotive retail a...

1 day ago · businesswire.com

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disord...

1 day ago · thefly.com

Lithia & Driveway price target raised to $350 from $320 at JPMorgan

JPMorgan raised the firm's price target on Lithia & Driveway to $350 from $320 and keeps an Overweight rating on the shares. The firm reduced franchise dealer estimates into the Q3 reports to reflect ...

1 month ago · benzinga.com

Tariffs Loom, But US Auto Dealers Hold Firm: Watch Lithia & Driveway And AutoNation

With tariff headwinds building and EV credits rolling off, U.S. Franchise Auto Dealerships maintain solid momentum on disciplined OEM pricing and balanced inventories; investors often gravitate to Lit...

1 month ago · zacks.com

Here's Why Lithia Motors (LAD) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago · marketbeat.com

These 4 Mid-Caps Just Announced Big Buyback Plans

In fact, each of the four names below has authorized repurchases worth more than 5% of its total market value, creating meaningful support for their stocks and potential upside for investors.